RESULTS: A total of 447 patients were evaluated. Of these, 118 were excluded because the mortality in 10 years was not obtained. Thus, 329 patients aged 62.9 ± 13.0 years were studied. Among them, 58.4% were men, and 44.4% died within ten years of hospitalization. The median FRS was 16 (14-18) %, and the ACC/AHA ). Patients who died had higher values of both scores. However, when we classified patients at high cardiovascular risk, only the ACC/AHA RS was associated with mortality (p <0.001). In the logistic regression analysis, both scores were associated with mortality at ten years (p <0.001).
INTRODUCTION
The ischemic heart diseases are the most common causes of death worldwide. 1 Among them are the acute coronary syndromes (ACS), which can be divided into myocardial infarction with ST-seg-
The present work is an observational retrospective cohort study that included patients aged ≥18 years, with ACS, who were admitted to the Coronary Intensive Care Unit (ICU) of the Hospital das Clínicas de Botucatu -UNESP, in the period from January 2005 to December 2006, and who had the exams for the calculation of cardiovascular risk scores. We excluded patients whose final outcome after ten years was not obtained or those who refused to participate in the study.
For the calculation of the sample size, we used the Fisher and Belle formula, with the following variables: mortality ten years after AMI of 30% to 40%, confidence interval of 95%, and a sampling error of 5%. The result was a minimum of 323 patients.
The clinical and demographic data and laboratory examinations were collected upon admission to the Coronary Care Unit. The systolic blood pressure, blood glucose, lipid profile used were those of the first measurement taken at the time of admission. The FRS and the ACC/AHA RS were calculated and the overall mortality after ten years of ACS was recorded. [5] [6] [7] In relation to acute coronary syndromes, they were classified as AMI with ST-segment elevation and non-ST-segment elevation ACS (AMI with no ST elevation and unstable angina). The diagnosis of the ACS was performed according to the guidelines by the American Heart Association. 11. 12 Systemic arterial hypertension (SAH) and the presence of diabetes mellitus (DM) were defined according to previous studies 13. 14 . Smoking was regarded as the current use of tobacco.
Laboratory evaluation
For the measurement of sodium, potassium, urea, creatinine, CT, HDL, creatine phosphokinase (CPK) and creatine phosphokinase-MB (CKMB), we used the dry chemical method (Ortho-Clinical Diagnostics Vitros 950®, Johnson & Johnson). CPK and CKMB were dosed every six hours after admission and the highest value was recorded.
Framingham risk score (FRS)
We calculated the Framingham risk score. Patients were considered at high cardiovascular risk when they presented a risk of death greater than 20%. For the calculation of risk, patients younger than 20 years old or older than 80 were classified into the youngest and oldest categories of age, respectively. 5.6 ment elevation and non-ST-segment elevation ACS. Despite the reduction tendency of mortality rates, ischemic heart diseases account for more than 1.8 million deaths every year, approximately 20% of all deaths in Europe. [1] [2] [3] [4] Thus, the identification of patients at risk of developing of coronary artery disease is crucial. The goal of the strategy of screening asymptomatic individuals is to have a more aggressive treatment and, consequently, a reduction of ischemic events and cardiovascular mortality. Among these scores are the Framingham risk score (FRS) and the score proposed by the American College of Cardiology and the American Heart Association (ACC/AHA RS). 5-7
Over the last two decades, risk scores have gone through significant changes in order to concentrate on the overall absolute risk as an important key for the assessment of individual risk. In addition, more recent studies seek to improve the performance of the scores already used with the introduction of serum markers of inflammation, heart failure, and myocardial injury. Until the present time, however, risk scores have been developed and validated almost exclusively in developed countries.
In addition, the scores have been built, in their majority, in populations with apparently no cardiovascular disease, so their conclusions relate to primary prevention and do not apply to patients with diagnosed coronary disease. For patients post ACS, some instruments of risk stratification have been developed, such as the Grace, Pursuit, and Timi scores. 8-10 However, these scores assess intra-hospital mortality or, at most, the mortality after six months of an acute coronary event. Thus, instruments that assess the long-term mortality, such as the Framingham RS and the ACC/AHA RS, have still not been validated for patients with a prior coronary event.
In view of these aspects, the objective of this study was to evaluate the performance of the Framingham RS and the ACC/AHA RS in predicting mortality in patients ten years after an ACS.
METHODS
The present study was approved by the Ethics Committee of our institution, under the protocol (61090116.1.0000.5411). The Informed Consent Form (ICF) was waived in cases which death was identified in the medical or administrative records of the hospital.
Risk score proposed by the American College of Cardiology and the American Heart Association (ACC/AHA)
We calculated the risk score proposed by the ACC/AHA. Patients were considered at high risk for atherosclerotic cardiovascular disease when they had a percentage greater than or equal to 7.5%. For the calculation of risk, patients younger than 40 years old or older than 80 were classified into the youngest and oldest categories of age, respectively. 7
STATISTICAL ANALYSIS
The data were presented as mean and standard deviation or median and percentiles of 25% and 75%. The categorical variables were analyzed using the c 2 test or Fisher's exact test. Continuous variables were analyzed by Student's t-test when they presented normal distribution and by the Mann-Whitney test for non-normal distribution. For the evaluation of score performance in relation to mortality, we used the ROC curve. We also used uni-and multivariate logistic regression analyses, adjusted for the variables, which were different in the univariate analysis, except for variables that were already included in the scores and those with multicollinearity. The level of significance was 5%.
RESULTS
We evaluated 447 patients with ACS admitted to the coronary ICU. Of these, 118 were excluded since their mortality ten years after admission to the ICU was not obtained. Thus, 329 patients with an average age of 62.9±13.0 years were studied. Out of that total, 58.4% were men, and 44.4% died within ten years after hospitalization. Of these, 63% presented non-ST-segment elevation ACS, while 37% had AMI with ST-segment elevation. After comparing these two groups of ACS, mortality was similar (p=0.97).
The median of the FRS was 16 (14-18%), with 17% of the patients classified at high cardiovascular risk. In relation to the ACC/AHA RS, the median was 18.5 (9.1-31.6%), with 79% of the patients classified at high cardiovascular risk, according to this score.
The demographic, clinical, and laboratory data of the patients evaluated and their relationship with tenyear mortality are presented in Table 1 . The patients who died were older and had higher values of creat-inine, urea, and potassium, and lower values of total cholesterol upon admission to the coronary ICU.
Furthermore, we found that the patients who progressed to death had higher scores, both on the FRS and the ACC/AHA RS. However, when we classified only patients with high cardiovascular risk, only the ACC/AHA RS was associated with mortality ( Table 2 ). The area under the curve (AUC) of the association between the FRS and ten-year mortality in patients who had ACS was 0.6307, with 95% CI 0.5708-0.6905 and p <0.001. The cut-off point of the score that is associated with the highest mortality is over 14.3%. With the cut-off point of 14.3%, sensitivity was 74.66%, specificity 42.62%, positive predictive 50.93%, and negative predictive value 67.83% (Figure 1) .
The area under the curve (AUC) of the association between the ACC/AHA RS and ten-year mortality in patients who had ACS was 0.7015, with 95% CI 0.6455-0.7576 and p <0.001. The cut-off point of the score that is associated with the highest mortality is over 23.56%. With the cut-off point of 23.56%, sensitivity was 50.00%, specificity 71.04%, positive predictive 57.94%, and negative predictive value 64.04% (Figure 1 ). There was an association between the FRS and the overall mortality after ten years in the univariate logistic regression (OR: 1.115; IC95%: 1.052-1.181; p<0.001) and in the multivariate analysis adjusted for creatinine and potassium (OR: 1.127; IC95%: 1.056-1.204, p<0.001). There was also an association between the ACC/AHA RS and the overall mortality after ten years in the univariate logistic regression (OR: 1.047; IC95%: 1.030-1.064; p<0.001) and in the multivariate analysis adjusted for creatinine and potassium (OR: 1.043; IC95%: 1.025-1.060, p<0.001).
DISCUSSION
The objective of this study was to evaluate the performance of two known risk scores for cardiovascular events in predicting mortality during the period of ten years in post-ACS patients. Our results show that both the FRS and the ACC/AHA RS were associated with mortality after ten years, with better performance by the ACC/AHA RS. In addition, for patients classified at high risk, only the ACC/AHA RS was associated with mortality after ten years.
The first aspect to be considered refers to the fact that, even though hospital mortality is relatively low in ACS, the same concept does not apply for longer periods of observation. Thus, in a period between one and ten years, patients with ACS present a mortality rate of around 10% and 45%, respectively. 1. 15 In our study, the mortality after ten years of follow-up was 44%. Our data are in line with those found in the literature, but they also show that, despite the advances introduced in the treatment of these patients, the long-term prognosis remains poor.
It is also important to note that there was no difference in mortality after ten years among the patients who had ACS with and without ST-segment elevation, and the same is true n in relation to the CPK and CKMB markers of myocardial injury. This fact is in agreement with studies that show that, in the long term, there is no difference in mortality between patients who had ACS with or without ST-segment elevation. [1] [2] [3] Another relevant aspect to be observed is that considering that approximately half of the patients with ACS will die in a period of ten years, the risk stratification of these patients becomes a priority. In this sense, the identification of patients at higher risk of unfavorable outcomes after the acute episode would allow for an individualized and more aggressive approach in these cases, improving the prognosis.
Taking into account the factors associated with ten-year outcomes, in our study, in addition to advanced age, higher values of the markers of renal function and potassium were also associated with greater mortality. This result is important because creatinine and potassium are not considered in most risk scores for coronary patients. [16] [17] [18] In addition, there is an association between the decrease in renal function, associated or not to hyperkalemia, with increased risk of cardiovascular events. 19. 20 The Framingham and ACC/AHA scores are well-established and used for risk stratification of asymptomatic individuals. [21] [22] [23] [24] [25] It is important to emphasize that our study was the first to assess and compare these scores in a population that has already presented coronary events. Furthermore, the use of these scores, even in a population that is mostly treated from a perspective of controlling risk factors and comorbidities, allows for the identification of patients who would benefit from more aggressive treatment. Another interesting point is that these scores are quick to be calculated and use laboratory examinations that are cheap and already part of the routine evaluation of patients with ACS.
In our study, both the FRS and the ACC/AHA RS were associated with mortality in ten years. Additionally, the ACC/AHA RS had a better performance, despite discreet. Another important finding was that for patients classified at high risk, only the ACC/AHA RS was associated with mortality after ten years. Our results as a whole suggest that, specifically for patients with ACS, the ACC/AHA RS may be a better tool than the FRS for risk stratification in this scenario. Finally, our study must be interpreted considering some limitations. This is a retrospective study, which included patients from a single center. Furthermore, the number of patients without information related to mortality after ten years was high. However, despite these restrictions, we believe that our data provide important information about the use of scores for risk stratification, in the long term, for patients with ACS.
CONCLUSION
Our data indicate that both the FRS and the ACC/ AHA RS were associated with mortality after ten years, with better performance by the ACC/AHA RS. In addition, for patients classified at high risk, only the ACC/AHA RS was associated with mortality after ten years. 
